Miles Dieffenbach

Miles Dieffenbach, the Managing Director of Investments at Carnegie Mellon University, oversees a $4 billion endowment. He shares how surviving cancer reshaped his perspective on resilience and investment decisions. The discussion dives into why 90% of limited partners might not benefit from venture capital, the pitfalls of seed funds, and the significant issues multi-stage funds face. He also addresses the evolving dynamics of founder-friendly approaches and the critical role that brand plays in LP decisions.